Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank13
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Percentile
P13
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-290750.00-84.4%
2025$-157701.00-105.0%
2024$3.15M-34.0%
2023$4.77M+1795.4%
2022$251399.00-47.3%
2021$477460.00+193.6%
2020$162600.00+349.0%
2019$36217.00-97.1%
2018$1.25M+414.2%
2017$-398642.00-